Stakeholder Engagement for Hepatitis C Virus Elimination

This Viewpoint describes factors necessary to eliminate hepatitis C virus, including access to point-of-care RNA testing and availability of treatment, and the stakeholders from the federal to the community level that must participate.

Corresponding Author: Louis P. Garrison Jr, PhD, The Comparative Health Outcomes, Policy, and Economics Institute, Department of Pharmacy, University of Washington, 1959 NE Pacific St, Health Sciences Building, H375, Box 357630, Seattle, WA 98195-7630 (lgarrisn@uw.edu).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.